Compare SHEN & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHEN | BLFS |
|---|---|---|
| Founded | 1902 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 910.8M | 923.5M |
| IPO Year | 1994 | 2013 |
| Metric | SHEN | BLFS |
|---|---|---|
| Price | $16.25 | $21.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $26.00 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 337.8K | 326.0K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $357,854,000.00 | $96,214,000.00 |
| Revenue This Year | $7.12 | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 9.08 | ★ 16.97 |
| 52 Week Low | $9.67 | $17.86 |
| 52 Week High | $17.35 | $29.57 |
| Indicator | SHEN | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 54.67 | 56.20 |
| Support Level | $12.66 | $21.35 |
| Resistance Level | $17.35 | $26.14 |
| Average True Range (ATR) | 1.00 | 1.03 |
| MACD | -0.07 | 0.10 |
| Stochastic Oscillator | 72.59 | 68.35 |
Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.